| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From The Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, University of California-Los Angeles School of Medicine, Los Angeles, California
Fibronectin (FN), expressed primarily by
macrophages, endothelial cells, and smooth muscle
cells, represents an integral feature of the rejection response
in transplant recipients. Here we demonstrate a unique pattern of
cellular FN expression in rat recipients of cardiac allografts rendered
tolerant in an infectious manner with either nondepleting CD4
mAb or regulatory spleen cells. Unlike in rejecting controls,
cellular FN in tolerant hosts was restricted to the graft vessels and
no vascular cell adhesion molecule-1 or intercellular adhesion
molecule-1 expression could be found, supporting the role of FN
in leukocyte sequestration at the graft site. The lack of myocardial FN
in tolerant rats, despite dense macrophage
infiltration, correlated with profound depression of Th1
(interleukin-2 and interferon-
) cytokines. Treatment with
CD4-depleting mAb prevented tolerance induction and restored myocardial
expression of FN in parallel with marked increase in the expression of
interleukin-2 and interferon-
mRNA/protein. Furthermore,
connective segment-1 peptide-facilitated adjunctive blockade of
FN-
4ß1 interactions in recipients conditioned with CD4 depleting
mAb, significantly depressed intragraft expression of
interleukin-2 and interferon-
mRNA/protein. Hence, the lack
of FN associated with infiltrating leukocytes plays an
important role in the maintenance of tolerance in transplant recipients
by depressing local expression of Th1 cytokines that otherwise
facilitate acute graft rejection.
This article has been cited by other articles:
![]() |
C. Moore, X.-D. Shen, F. Gao, R. W. Busuttil, and A. J. Coito Fibronectin-{alpha}4{beta}1 Integrin Interactions Regulate Metalloproteinase-9 Expression in Steatotic Liver Ischemia and Reperfusion Injury Am. J. Pathol., February 1, 2007; 170(2): 567 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mittelbrunn, A. Molina, M. M. Escribese, M. Yanez-Mo, E. Escudero, A. Ursa, R. Tejedor, F. Mampaso, and F. Sanchez-Madrid VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses PNAS, July 27, 2004; 101(30): 11058 - 11063. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Amersi, X.-D. Shen, C. Moore, J. Melinek, R. W. Busuttil, J. W. Kupiec-Weglinski, and A. J. Coito Fibronectin-{alpha}4{beta}1 Integrin-Mediated Blockade Protects Genetically Fat Zucker Rat Livers from Ischemia/Reperfusion Injury Am. J. Pathol., April 1, 2003; 162(4): 1229 - 1239. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |